Optimal immunosuppressive clinical regimen in liver transplantation
Farges, O.; Samuel, D.; Bismuth, H.
Transplantation Proceedings 26(5): 2676-2678
1994
ISSN/ISBN: 0041-1345 PMID: 7940838 Document Number: 435859
Document emailed within 1 workday
Related Documents
Touraine, J.L.; Lefrançois, N.; Dubernard, J.M.; Garnier, J.L.; Eygonnet, J.P.; Gibelin, N.; Bétuel, H.; Traeger, J. 1987: Place of antilymphocyte globulins in the immunosuppressive regimen for kidney transplantation Transplantation Proceedings 19(1 Part 3): 1881Arnold, J.C.; Theilmann, L. 1995: Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation Zeitschrift für Gastroenterologie 33(10): 624-625
Gugenheim, J.; Samuel, D.; Saliba, F.; Castaing, D.; Bismuth, H. 1987: Use of flexible triple-drug immunosuppressive therapy in liver transplantation Transplantation Proceedings 19(5): 3805-3807
Tanaka, M.; Otobe, Y.; Hashimoto, T.; Shimizu, Y.; Suzuki, T.; Nakamura, Y.; Itoh, K.; Satoh, M.; Ueda, N.; Manabe, T. 1996: Reduction of immunosuppressive agents after living related donor liver transplantation Transplantation Proceedings 28(4): 2402-2403
Wonigeit, K.; Nashan, B.; Schwinzer, R.; Schlitt, H.J.; Kurrle, R.; Racenberg, J.; Seiler, F.; Ringe, B.; Pichlmayr, R. 1989: Use of a monoclonal antibody against the T cell receptor for prophylactic immunosuppressive treatment after liver transplantation Transplantation Proceedings 21(1 Part 2): 2258-2259
Bechstein, W.O.; Neuhaus, P.; McMaster, P.; Calne, R.; Pichlmayr, R.; Otto, G.; Williams, R.; Ericzon, B.G.; Bismuth, H. 1996: Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation Transplantation Proceedings 28(2): 1008-1010
Imataki, O.; Aoyama, T.; Tamai, Y.; Kawakami, K. 2007: Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(10): 1633-1636
Eklund, B.; Ahonen, J.; Häyry, P.; Kauste, A.; von Willebrand, E.; Lindström, B.L. 1981: Comparison of two different immunosuppressive dosages of methylprednisolone in clinical renal transplantation Scandinavian Journal of Urology and Nephrology. Supplementum 64: 179-184
Du Toit, D.F.; Heydenrych, J.J. 1986: The application, mechanism of action and side-effects of immunosuppressive agents in clinical transplantation South African Medical Journal 70(11): 687-691
Arranz, R.; Otero, M.J.; Ramos, R.; Steegmann, J.L.; Lamana, M.L.; Tomás, J.F.; de la Cámara, R.; Figuera, A.; Vázquez, L.; Fernádez-Rañada, J.M. 1994: Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy Bone Marrow Transplantation 13(4): 383-387
Carter, L.; Zolezzi, M.; Lewczyk, A. 2013: An updated review of the optimal lithium dosage regimen for renal protection Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 58(10): 595-600
Deltenre, M.; De Bruyne, L.; Ntounda, R.; De Koster, E.; Lamy, V. 1998: The search for optimal Helicobacter pylori eradication regimen: a mid 1997 update Acta Gastro-Enterologica Belgica 61(3): 344-347
Adam, R.; Reynes, M.; Bao, Y.M.; Astarcioglu, I.; Azoulay, D.; Chiche, L.; Bismuth, H. 1993: Impact of glycogen content of the donor liver in clinical liver transplantation Transplantation Proceedings 25(1 Part 2): 1536-1537
Sakita, M.; Yamane, T.; Kasuga, M.; Torii, T.; Imai, H.; Kageyama, N.; Fujita, Y.; Majima, S. 1982: Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(10): 1755-1764
Wang, W.-l.; Zheng, S.-s.; Xu, X.; Liang, T.-b.; Jin, J.; Shen, Y.; Zhang, M.; Wu, J. 2005: Clinical evaluation of emergency liver transplantation for patients with benign end-stage liver diseases Zhonghua Yi Xue Za Zhi 85(49): 3460-3463
Song, Y.; Xue, W.; Tian, P.; Ding, X.; Pan, X.; Yan, H.; Hou, J.; Feng, X.; Xiang, H.; Tian, X.; Qin, G.; Fan, X. 2011: Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China European Journal of Clinical Pharmacology 67(6): 553-562
Jiménez, S.; Zamora, J.; Muriel, A.; Pascual, J. 2008: Is it possible to sustain adequate immunosuppressive efficacy minimizing the nephrotoxicity with a regimen including low doses of calcineurin inhibitors or sirolimus? Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 28(Suppl 2): 40-41
Iarovaia, E.B.; Rostapshova, T.V.; Susekov, A.V.; Kukharchuk, V.V. 1993: The choice of the optimal regimen for apheresis of the low-density lipoproteins in patients with familial hypercholesterolemia by using mathematical modelling Kardiologiia 33(10): 50
Denecke, C.; Weiss, S.; Biebl, M.; Fritz, J.; Dziodzio, T.; Aigner, F.; Sucher, R.; Brandl, A.; Bösmüller, C.; Pratschke, J.; Öllinger, R. 2016: An Arterial Conduit is Not a Risk Factor for Survival Following Orthotopic Liver Transplantation: An Analysis of 20 Years of Liver Transplantation in Innsbruck Annals of transplantation 21: 321-328
Ishine, N.; Tanaka, N.; Yagi, T.; Oishi, M.; Ishikawa, T.; Orita, K. 1996: Postreperfusion syndrome in swine liver transplantation: comparison between orthotopic liver transplantation and total hepatectomy with portacaval shunt using aortic graft Transplantation Proceedings 28(3): 1756-1758